Chehade, R. E. H. Et Al. 2024. 59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. ONCOLOGIST , vol.29, no.Supplement_1 , 1.

Chehade, R. E. H., Semaan, K., Saliby, R. M., Saad, E., Nawfal, R., Machaalani, M., ... Eid, M.(2024). 59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. ONCOLOGIST , vol.29, no.Supplement_1, 1.

Chehade, Razane Et Al. "59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors," ONCOLOGIST , vol.29, no.Supplement_1, 1, 2024

Chehade, Razane E. Et Al. "59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors." ONCOLOGIST , vol.29, no.Supplement_1, pp.1, 2024

Chehade, R. E. H. Et Al. (2024) . "59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors." ONCOLOGIST , vol.29, no.Supplement_1, p.1.

@article{article, author={Razane El Hajj Chehade Et Al. }, title={59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors}, journal={ONCOLOGIST}, year=2024, pages={1} }